Prodrug activation in human liver microsomes assessed as (S)-5-(furo[3,2-b]pyridin-2-yl)-5-((6-methoxy-1-oxoisoindolin-2-yl)methyl)imidazolidine-2,4-d...

Basic Information

ID: ALA4057820

Type: ADME

Description: Prodrug activation in human liver microsomes assessed as (S)-5-(furo[3,2-b]pyridin-2-yl)-5-((6-methoxy-1-oxoisoindolin-2-yl)methyl)imidazolidine-2,4-dione formation

Format: BAO_0000019

Organism: Homo sapiens

Tissue: Liver

Subcellular Fraction: microsome

Target: Liver(ALA613419)

Document: ALA4052764

Prodrug activation in human liver microsomes assessed as (S)-5-(furo[3,2-b]pyridin-2-yl)-5-((6-methoxy-1-oxoisoindolin-2-yl)methyl)imidazolidine-2,4-dione formation: 1

Associated Items: Associated Bioactivities Associated Compounds

Activity Charts

Bioactivity

Activity Types for Assay ALA4057820

Drug metabolism

Total(1)

Parent Molecular Weight	ALogP	Polar Surface Area
506.52	2.79	2.79

Parent Molecular Weight

ALogP

Polar Surface Area

506.52

2.79

Prodrug activation in human liver microsomes assessed as (S)-5-(furo[3,2-b]pyridin-2-yl)-5-((6-methoxy-1-oxoisoindolin-2-yl)methyl)imidazolidine-2,4-d...

Basic Information

Activity Charts

Compound Summary